Navigation Links
Cancer Antibodies: Drug Target Atlas and Competitive Outlook
Date:11/15/2012

e 102: Target Strategy Development Profiles of Antibody Drugs for the Treatment of Neuroendocrine Cancer (general) 852Table 103: Target Strategy Development Profiles of Antibody Drugs for the Treatment of non-Hodgkin's Lymphoma 853Table 104: The Competition through Close Mechanistic Approximation between non-Hodgkin's Lymphoma Drugs 855Table 105: Target Strategy Development Profiles of Antibody Drugs for the Treatment of Non-Small Cell Lung Cancer 857Table 106: The Competition through Close Mechanistic Approximation between Non-Small Cell Lung Cancer Drugs 859Table 107: Target Strategy Development Profiles of Antibody Drugs for the Treatment of Oesophageal Cancer 860Table 108: The Competition through Close Mechanistic Approximation between Oesophageal Cancer Drugs 862Table 109: Target Strategy Development Profiles of Antibody Drugs for the Treatment of Oral Cancer 863Table 110: Target Strategy Development Profiles of Antibody Drugs for the Treatment of Osteo Sarcoma 864Table 111: The Competition through Close Mechanistic Approximation between Osteo Sarcoma Drugs 864Table 112: Target Strategy Development Profiles of Antibody Drugs for the Treatment of Ovarian Cancer 865Table 113: The Competition through Close Mechanistic Approximation between Ovarian Cancer Drugs 867Table 114: Target Strategy Development Profiles of Antibody Drugs for the Treatment of Pancreatic Cancer 868Table 115: The Competition through Close Mechanistic Approximation between Pancreatic Cancer Drugs 870Table 116: Target Strategy Development Profiles of Antibody Drugs for the Treatment of Peritoneal Cancer 871Table 117: The Competition through Close Mechanistic Approximation between Peritoneal Cancer Drugs 872Table 118: Target Strategy Development Profiles of Antibody Drugs for the Treatment of Pituitary Adenoma 873Table 119: Target Strategy Development Profiles of Antibody Drugs for the Treatment of Prostate Cancer 874Table 120: The Competition through Close Mechanistic Approximation between Prost
'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. MarketsandMarkets: Lung Cancer Drugs Market in G7 Countries Worth $13 Billion by 2020
2. Virobays Spectrum-Selective Cathepsin Inhibitor Shows Efficacy in Bone Cancer Model
3. Biocept and Academic Collaborators to Present Posters at San Antonio Breast Cancer Symposium on Circulating Tumor Cells (CTCs)
4. NKTR-102 Demonstrates Synergistic Anti-Tumor Activity in Combination with Pegylated Liposomal Doxorubicin in Platinum-Resistant Ovarian Cancer
5. Members of Congress, Cancer Experts Address Impact of Genetic Testing on Cancer
6. Masaryk Memorial Cancer Institute Reduces Losses and Administrative Overhead With Ekahau RTLS
7. BBVA Foundation Unites the Efforts of Massachusetts General Hospital and Barcelonas Vall dHebron Hospital in Biomarker Research for Personalized Cancer Therapies
8. MarketsandMarkets: Global Prostate Cancer Therapeutics Market worth $6,457 Million by 2020
9. New research points to benefits of innovative cobas® HPV test for primary screening as Englands cervical cancer screening programme includes the test in current HPV "triage" rollout
10. A New Type of Dendritic Cell-Based Cancer Vaccine has Received Approval for Clinical Tests and at the Same Time Secures Substantial Financing
11. US Oncology Research Affiliated Physician to Present Findings From Innovative Clinical Trial at 2011 CTRC-AACR San Antonio Breast Cancer Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Die Übersetzungen wurden von PRNewswire ... der englischen Version handelt es sich um ... Teilnehmer einer groß angelegten Asthmaumfrage halten ihren Zustand für ... -Definition [1] als kontrolliert gelten können ... von vier Denkweisen zugeordnet werden können, die alle von ...
(Date:5/23/2013)... 23, 2013 Venaxis, Inc. (Nasdaq:   APPY), ... obtaining FDA clearance and commercializing its rapid, protein biomarker-based ... of an underwritten public offering of 10,000,000 shares of ... shares of its common stock at an exercise price ... price of $1.25 per share and related warrant.  Venaxis ...
(Date:5/23/2013)... Can economic incentives such as gift ... of the public to increase their donations of blood? ... Carey Business School Assistant Professor Mario Macis says ... large body of recent research that supports their argument, ... issue of Science that the World Health Organization and ...
(Date:5/23/2013)... Patheon Inc ., a leading provider of contract development ... host a complimentary webinar on “Cleaning Validation: Science, Risk ... 2013 at 11 a.m. Eastern Standard Time. , ... for cleaning validation. Many companies have incorporated their ... of risk. Some companies have chosen to avoid ...
Breaking Biology Technology:Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 2Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 3Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 4Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 5Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 6Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 7Venaxis Announces Pricing of Offering of Common Stock and Warrants 2Venaxis Announces Pricing of Offering of Common Stock and Warrants 3Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 2Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 3Patheon to Present on “Cleaning Validation: Science, Risk and Novel Approaches to Testing” 2
... 29 SCOLR Pharma, Inc.,(Amex: DDD ) today ... Thursday, August 7, 2008, at 8:30 a.m. Eastern. Daniel ... a conference call at 11:30,a.m. Eastern, to discuss the ... in the,conference call by dialing +1 888 680 0878 ...
... to Attract a Record Number of ... ... the world,s,leading online medical device and diagnostics job board and career ... September 8, 2008. The event will take place at the Minneapolis,Airport ...
... Ill., July 29 The Board of,Directors of Baxter ... dividend of $0.2175 per share of Baxter common stock., ... rate, which was,increased earlier this year by 30 percent. ... shareholders of record as of September 10,2008., Baxter ...
Cached Biology Technology:SCOLR Pharma, Inc. Schedules Second Quarter 2008 Financial Results Conference Call for August 7, 2008 at 11:30 A.M. Eastern 2DeviceSpace(TM) to Host Medical Device and Diagnostics Career Fair in Minneapolis 2
(Date:5/24/2013)... expressed concern in the ongoing public health debate is ... that are nutrient dense. A new study, "Vegetable ... Nutrients Per Penny," published in the journal PLOS ... best nutritional values in the produce aisle, providing one ... other raw vegetables and delivering one of the most ...
(Date:5/24/2013)... and grow by avoiding detection and destruction by the ... to eliminate cancer cells; however, there are many factors ... Regulatory T cells are immune cells that function to ... the Journal of Clinical Investigation , researchers led ... T cells that infiltrate tumors express proteins that can ...
(Date:5/24/2013)... against Alzheimer,s disease, scientists have focused among other factors ... After all, it is the accumulation of A-beta that causes ... point for the formation of A-beta is APP. Alessia Soldano ... the function of APPL the fruit-fly version of APP ... Alessia Soldano (VIB/KU Leuven): "We have discovered that APPL ensures ...
Breaking Biology News(10 mins):New research shows that potatoes provide one of the best nutritional values per penny 2A new strategy required in the search for Alzheimer's drugs? 2
... MD, received the 2010 Recognition Award for Scientific Accomplishments ... Monday, May 17. , Dr. Downey, Executive Vice President ... Immunology at National Jewish Health, has over 190 publications ... authors more than 5,000 times, putting him in the ...
... - (May 17, 2010) In the Opening Session ... National Biotechnology Conference, AAPS President Danny D. Shen, Ph.D., ... contributions to the pharmaceutical sciences: Excellence in ... , From ANP Technologies, Inc.: Ray Yin; Yli ...
... Ind. - Using NASA satellite data and Google Earth, ... North Korea has been logging in what is designated ... Shao, professor of geo-eco-informatics, studies the Mount Paekdu Biosphere ... many researchers are unable to visit North Korea, Shao ...
Cached Biology News:Gregory Downey, M.D., of National Jewish Health, honored for scientific accomplishments 2AAPS announces 2010 NBC award winners 2NASA, Google data show North Korea logging in protected area 2
... reads and processes raw microarray ... data for analysis. ,Package ... 1-year license for Feature Extraction ... CD-ROM containing Feature Extraction software ...
... CHEMICONs ELF 97 Cytological Labeling Kit ... facilitate the detection of cellular targets, including ... 97 Cytological Labeling Kit contains the patented ... brightly fluorescent yellow-green precipitate at the site ...
... between the various commercial and lab-prepared glass ... the length and GC content of the ... protocol employed all influence the optimal hybridization ... all the different variables to consider, it ...
... UltraPure Agarose and SYBR Safe DNA Gel Stain combo ... money versus buying these same products separately ... to ethidium bromide Eliminates ... resolves DNA and RNA fragments from 100 bp to ...
Biology Products: